Skip to main content
Premium Trial:

Request an Annual Quote

Singular Genomics Systems Raises $258M in Upsized IPO

NEW YORK – Singular Genomics Systems went public on the Nasdaq on Thursday after the firm priced its initial public offering of approximately 11.7 million shares at $22 per share the previous day, for anticipated gross proceeds of about $258.1 million before underwriting discounts, commissions, and other expenses.

In a Wednesday filing with the US Securities and Exchange Commission, the San Diego-based sequencing technology firm added nearly 2 million more shares to the offering. Previously, it had targeted a $187 million IPO.

Shares began trading on Thursday on the Nasdaq and rose to $29.00 per share before closing up 17 percent at $25.72.

JP Morgan, Goldman Sachs, Bank of America, and Cowen acted as joint bookrunning managers for the offering and as representatives of the underwriters. UBS also acted as a bookrunning manager. The underwriters have a 30-day option to purchase up to 1.5 million shares.

The Scan

NFTs for Genome Sharing

Nature News writes that non-fungible tokens could be a way for people to profit from sharing genomic data.

Wastewater Warning System

Time magazine writes that cities and college campuses are monitoring sewage for SARS-CoV-2, an approach officials hope lasts beyond COVID-19.

Networks to Boost Surveillance

Scientific American writes that new organizations and networks aim to improve the ability of developing countries to conduct SARS-CoV-2 genomic surveillance.

Genome Biology Papers on Gastric Cancer Epimutations, BUTTERFLY, GUNC Tool

In Genome Biology this week: recurrent epigenetic mutations in gastric cancer, correction tool for unique molecular identifier-based assays, and more.